Merryn Voysey Selected Research

ChAdOx1 nCoV-19

7/2022	An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
12/2021	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
1/2021	Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
1/2021	Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
1/2021	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
1/2021	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
1/2020	Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merryn Voysey Research Topics

Disease

19	Infections 01/2022 - 01/2013
14	Typhoid Fever (Typhoid) 11/2021 - 01/2016
11	COVID-19 07/2022 - 01/2020
10	Diphtheria 01/2022 - 02/2015
7	Whooping Cough (Pertussis) 01/2022 - 02/2015
7	Fever (Fevers) 10/2021 - 02/2012
6	Tetanus 01/2022 - 02/2015
6	Poliomyelitis (Polio) 01/2019 - 02/2015
5	Pneumococcal Infections 01/2022 - 05/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 04/2015 - 05/2009
3	Birth Weight (Birth Weights) 01/2022 - 02/2012
3	Pain (Aches) 12/2021 - 01/2018
3	Hepatitis B 01/2021 - 01/2016
3	Pharyngitis (Sore Throat) 01/2021 - 09/2014
3	Premature Birth (Birth, Premature) 01/2019 - 02/2012
3	Ovarian Neoplasms (Ovarian Cancer) 06/2014 - 01/2013
3	Neoplasms (Cancer) 06/2014 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 05/2012 - 05/2009
2	Headache (Headaches) 12/2021 - 01/2020
2	Asymptomatic Infections 11/2021 - 01/2018
2	Cough 10/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 01/2016
2	Bacteremia 01/2017 - 01/2017
2	Measles 10/2016 - 01/2016
2	Mumps 10/2016 - 01/2016
2	Rubella (German Measles) 10/2016 - 01/2016
2	Human Influenza (Influenza) 04/2016 - 01/2016
2	Anxiety Disorders (Anxiety Disorder) 05/2015 - 12/2013
2	Disease Progression 01/2013 - 07/2011
2	Pulmonary Hypertension 10/2011 - 03/2010
2	Respiratory Insufficiency (Respiratory Failure) 10/2011 - 03/2010
1	Meningitis 01/2022
1	Mania (Manias) 01/2021
1	Japanese Encephalitis 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Salmonella Infections (Salmonellosis) 01/2020
1	Chills 01/2020
1	Paramyxoviridae Infections (Parainfluenza) 01/2019
1	Pneumococcal Pneumonia 01/2019
1	Infant Death 10/2017
1	Cerebral Palsy (Spastic Diplegia) 10/2017
1	Paratyphoid Fever 01/2017
1	Vaccinia 04/2016

Drug/Important Bio-Agent (IBA)

37	VaccinesIBA 07/2022 - 01/2013
15	Conjugate VaccinesIBA 11/2021 - 02/2015
9	ChAdOx1 nCoV-19IBA 07/2022 - 01/2020
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2012
6	AntigensIBA 01/2022 - 01/2016
6	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021 - 01/2016
4	Nucleic AcidsIBA 07/2022 - 01/2021
4	Polysaccharides (Glycans)IBA 11/2021 - 01/2018
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 02/2012
3	AntibodiesIBA 01/2022 - 11/2021
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2019 - 01/2016
3	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2019 - 06/2015
3	Fenofibrate (CiL)FDA LinkGeneric 03/2012 - 05/2009
2	MenACWYIBA 10/2021 - 01/2020
2	TCVSIBA 01/2020 - 01/2019
2	LipopolysaccharidesIBA 01/2017 - 10/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2015 - 01/2010
2	PlatinumIBA 06/2014 - 01/2013
2	Insulin (Novolin)FDA Link 05/2012 - 03/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011 - 03/2010
1	sinovac COVID-19 vaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	P-2 (P 2)IBA 10/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	MelatoninIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	MagnesiumIBA 10/2017
1	EnzymesIBA 05/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	pertussis toxoidIBA 01/2017
1	ProteomeIBA 01/2017
1	Hemagglutinins (Hemagglutinin)IBA 01/2017
1	pertactin FDA Link 01/2017
1	N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA 01/2017
1	FlagellinIBA 01/2017
1	Heterophile AntigensIBA 10/2016
1	NucleoproteinsIBA 04/2016
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 04/2016
1	Ebola VaccinesIBA 04/2016
1	Glycoproteins (Glycoprotein)IBA 04/2016
1	Biological ProductsIBA 03/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2016

Therapy/Procedure

11	Therapeutics 01/2021 - 03/2010
3	Drug Therapy (Chemotherapy) 06/2014 - 01/2013
1	Cardiopulmonary Resuscitation (CPR) 01/2021
1	Intramuscular Injections 01/2020